HOME >> MEDICINE >> NEWS
Controversial drug shown to act on brain protein to cut alcohol use

A naturally occurring hallucinogen advocated by some clinicians as a potent anti-addiction drug has been rigorously studied for the first time, confirming its ability to block alcohol craving in rodents, and clarifying how it works in the brain. The new research findings about the drug Ibogaine open the way for development of other drugs to reverse addiction without Ibogaine's side effects, potentially adding to the small arsenal of drugs that effectively combat addiction.

Derived from a West African shrub, Ibogaine has been championed for years by a cadre of clinicians and drug treatment advocates impressed with its ability to reverse withdrawal symptoms and craving for alcohol and various drugs of abuse. It has been used outside of the U.S. to treat addiction by American and other clinicians. But its side effects, including hallucinations, which made it popular in the 1960s drug culture, and evidence of toxicity to certain nerve cells in rodent studies have discouraged careful studies of its clinical potential against drug and alcohol addiction. The FDA has not approved use of Ibogaine in the U.S.

Scientists at UCSF's Ernest Gallo Clinic and Research Center have now shown definitively in experiments with mice and rats that Ibogaine does reduce alcohol consumption, and they have determined that it does so by increasing the level of a brain protein known as glial cell line-derived neurotrophic factor, or GDNF. In a separate study, they demonstrated that GDNF by itself decreases alcohol consumption.

The research is being published in the January 19 issue of The Journal of Neuroscience.

"By identifying the brain protein that Ibogaine regulates to reduce alcohol consumption in rats, we have established a link between GDNF and reversal of addiction -- knowledge of a molecular mechanism that should allow development of a new class of drugs to treat addiction without Ibogaine's side effects," said Dorit Ron, PhD, UCSF associate professor of
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Jan-2005


Page: 1 2 3

Related medicine news :

1. Controversial Atkins Diet may be beneficial for people with epilepsy
2. Controversial performance enhancer "andro" affects brains as well as brawn, say UMass researchers
3. Cartilage repair techniques shown to restore patient mobility and reduce pain
4. Sprinklers shown effective in slowing dorm fires
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Pioglitazone shown to reverse thickening of carotid artery wall
9. Isolated soy protein shown to benefit type 2 diabetics, study indicates
10. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
11. Increased risk of cardiovascular disease shown in PCOS patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Controversial drug shown act brain protein cut alcohol use

(Date:3/31/2015)... March 31, 2015 The New ... Care Administrators (ACHCA) elected two administrators from Windsor ... long-term care in New Jersey, to two key ... new officers. Robert Reyes, administrator for Abingdon Care ... president, and Yael Herman, administrator of Canterbury Care ...
(Date:3/31/2015)... March 31, 2015 Williams Comfort ... repair visit when their home comfort is at ... make the visit fit into the customer’s schedule, ... fast, quality repair at requested times. , ... commercial customers in the Indianapolis area can visit ...
(Date:3/31/2015)... 31, 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... developed new-onset Type 2 diabetes due to the use ... the federal multidistrict litigation now underway in U.S. District ... issued on March 26th, jury selection for the proceeding’s ... (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502) , ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... Practice Edition 2, bringing the industry’s most advanced ... the healthcare community. Physicians can now experience the ... a trusted source, offering value-added support services that ... (EHR) systems. , “QMedET is proud to provide ...
(Date:3/31/2015)... CirugiaPlastica-Mexico.net , an exclusive plastic ... company, announced today an expansion of providers in ... most experienced and committed plastic surgeons in Mexico, ... elegant, life-altering cosmetic enhancements. Overall, a larger number ... in Mexico due to the improved technology, greater ...
Breaking Medicine News(10 mins):Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 3Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4
(Date:3/31/2015)... PARIS , March 31, 2015 ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced ... CHU de Grenoble (university hospital center). The CHU de ... France to propose to its gastroenterology, interventional ... research and a higher standard of care thanks to ...
(Date:3/31/2015)... Mar. 30, 2015 Research and Markets ... of the "Eurpoean Automatic External Defibrillators (AED) ... Public Access Market, Hospitals, Alternate Care Market, Home) ... offering. The European automated external defibrillator ... CAGR of 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... Mich. , March 31, 2015  The efficacy ... was highlighted in a recently published study 1 ... infection prevention research team, including Curtis Donskey , ... was run for the same length of time from ... xenon (PU-UV) unit.  The results showed surprisingly low pathogen ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4
Cached News: